BankPlus Trust Department’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.1K Hold
610
– – 0.02% 244
2026
Q1
$85K Sell
610
-40
-6% -$5.6K 0.02% 229
2025
Q4
$79.8K Hold
650
– – 0.02% 227
2025
Q3
$72.2K Hold
650
– – 0.02% 229
2025
Q2
$72.1K Buy
650
+500
+333% +$53.2K 0.02% 212
2025
Q1
$16.8K Sell
150
-35
-19% -$3.61K 0.01% 321
2024
Q4
$17.1K Buy
+185
New +$16.7K 0.01% 304

Other funds holding GILD

BankPlus Trust Department's GILD Position: Q2 2026 in Review

BankPlus Trust Department held its Gilead Sciences (GILD) position steady in Q2 2026 at 610 shares worth $77.1K. The position accounts for 0.02% of the portfolio, ranked #244.

BankPlus Trust Department first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $85K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • BankPlus Trust Department held 610 shares of Gilead Sciences worth $77.1K as of Q2 2026.
  • BankPlus Trust Department left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.02% of BankPlus Trust Department's portfolio in Q2 2026, its #244 holding.
  • BankPlus Trust Department first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • BankPlus Trust Department's Gilead Sciences position peaked at $85K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on BankPlus Trust Department's 13F filing for Q2 2026, filed 28 Jul 2026.